Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Colleen Kusy's Stock Ratings
Baird Analyst
Colleen Kusy is an analyst at Baird. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
-7.36%
Smart Score
Overall Average Return Percentile
21st
Number of Ratings
64
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/18/2025 | NUVL | Buy Now | Nuvalent | $104.23 | 51.59% | $112 → $158 | Maintains | Outperform | Get Alert | |
| 11/11/2025 | COGT | Buy Now | Cogent Biosciences | $40.48 | -16.01% | $14 → $34 | Maintains | Neutral | Get Alert | |
| 10/31/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 111.81% | $50 → $52 | Maintains | Outperform | Get Alert | |
| 10/03/2025 | OCUL | Buy Now | Ocular Therapeutix | $14.24 | 68.54% | $17 → $24 | Maintains | Outperform | Get Alert | |
| 08/15/2025 | CLYM | Buy Now | Climb Bio | $3.62 | 148.62% | → $9 | Initiates | → Outperform | Get Alert | |
| 07/18/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 103.67% | $47 → $50 | Maintains | Outperform | Get Alert | |
| 06/25/2025 | NUVL | Buy Now | Nuvalent | $104.23 | 7.45% | $105 → $112 | Maintains | Outperform | Get Alert | |
| 06/16/2025 | ELVN | Buy Now | Enliven Therapeutics | $17.26 | 201.27% | $40 → $52 | Maintains | Outperform | Get Alert | |
| 06/04/2025 | AGEN | Buy Now | Agenus | $3.71 | 61.73% | $4 → $6 | Maintains | Neutral | Get Alert | |
| 05/13/2025 | AGEN | Buy Now | Agenus | $3.71 | 7.82% | $3 → $4 | Maintains | Neutral | Get Alert | |
| 05/08/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 91.45% | $55 → $47 | Maintains | Outperform | Get Alert | |
| 03/13/2025 | OCS | Buy Now | Oculis Holding | $20.59 | 99.13% | $37 → $41 | Maintains | Outperform | Get Alert | |
| 03/12/2025 | AGEN | Buy Now | Agenus | $3.71 | -19.14% | $6 → $3 | Maintains | Neutral | Get Alert | |
| 12/05/2024 | CHRS | Buy Now | Coherus BioSciences | $1.37 | 337.96% | $4 → $6 | Maintains | Outperform | Get Alert | |
| 11/15/2024 | ELVN | Buy Now | Enliven Therapeutics | $17.26 | 131.75% | $32 → $40 | Maintains | Outperform | Get Alert | |
| 11/13/2024 | SYRE | Buy Now | Spyre Therapeutics | $33.44 | 94.37% | $50 → $65 | Maintains | Outperform | Get Alert | |
| 11/08/2024 | CHRS | Buy Now | Coherus BioSciences | $1.37 | 191.97% | $8 → $4 | Maintains | Outperform | Get Alert | |
| 11/07/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 124.03% | $92 → $55 | Maintains | Outperform | Get Alert | |
| 09/23/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 274.75% | $96 → $92 | Maintains | Outperform | Get Alert | |
| 08/14/2024 | MRSN | Buy Now | Mersana Therapeutics | $27.91 | -89.25% | $4 → $3 | Maintains | Neutral | Get Alert | |
| 08/09/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 291.04% | $86 → $96 | Maintains | Outperform | Get Alert | |
| 08/08/2024 | OCUL | Buy Now | Ocular Therapeutix | $14.24 | 19.38% | $18 → $17 | Maintains | Outperform | Get Alert | |
| 07/26/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 250.31% | $100 → $86 | Maintains | Outperform | Get Alert | |
| 07/23/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 307.33% | $100 → $100 | Maintains | Outperform | Get Alert | |
| 07/01/2024 | CHRS | Buy Now | Coherus BioSciences | $1.37 | 483.94% | $9 → $8 | Maintains | Outperform | Get Alert | |
| 06/28/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 307.33% | $100 → $100 | Maintains | Outperform | Get Alert | |
| 06/11/2024 | OCS | Buy Now | Oculis Holding | $20.59 | 79.7% | $35 → $37 | Maintains | Outperform | Get Alert | |
| 06/11/2024 | ELVN | Buy Now | Enliven Therapeutics | $17.26 | 85.4% | → $32 | Initiates | → Outperform | Get Alert | |
| 05/02/2024 | SYRE | Buy Now | Spyre Therapeutics | $33.44 | 49.51% | → $50 | Initiates | → Outperform | Get Alert | |
| 03/19/2024 | OCS | Buy Now | Oculis Holding | $20.59 | 69.99% | $64 → $35 | Maintains | Outperform | Get Alert | |
| 03/12/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.10 | 174.88% | $27 → $25 | Reiterates | Outperform → Outperform | Get Alert | |
| 02/29/2024 | MRSN | Buy Now | Mersana Therapeutics | $27.91 | -82.09% | $1 → $5 | Maintains | Neutral | Get Alert | |
| 02/23/2024 | NUVL | Buy Now | Nuvalent | $104.23 | 0.74% | → $105 | Initiates | → Outperform | Get Alert | |
| 02/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 229.94% | → $81 | Reiterates | Outperform → Outperform | Get Alert | |
| 01/23/2024 | CHRS | Buy Now | Coherus BioSciences | $1.37 | 556.93% | $11 → $9 | Maintains | Outperform | Get Alert | |
| 01/17/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 229.94% | $71 → $81 | Maintains | Outperform | Get Alert | |
| 11/17/2023 | CHRS | Buy Now | Coherus BioSciences | $1.37 | 702.92% | → $11 | Initiates | → Outperform | Get Alert | |
| 09/14/2023 | OCUL | Buy Now | Ocular Therapeutix | $14.24 | 26.4% | → $18 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/01/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 185.13% | $115 → $70 | Maintains | Outperform | Get Alert | |
| 07/28/2023 | MRSN | Buy Now | Mersana Therapeutics | $27.91 | -96.42% | $7 → $1 | Downgrade | Outperform → Neutral | Get Alert | |
| 06/20/2023 | SURF | Buy Now | Surface Oncology | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 06/13/2023 | OCUL | Buy Now | Ocular Therapeutix | $14.24 | -15.73% | $10 → $12 | Maintains | Outperform | Get Alert | |
| 06/08/2023 | OCS | Buy Now | Oculis Holding | $20.59 | 181.69% | → $58 | Initiates | → Outperform | Get Alert | |
| 06/06/2023 | AGEN | Buy Now | Agenus | $3.71 | 115.63% | → $8 | Initiates | → Outperform | Get Alert | |
| 05/04/2023 | SURF | Buy Now | Surface Oncology | — | — | → $6 | Maintains | Outperform | Get Alert | |
| 05/04/2023 | ISEE | Buy Now | IVERIC bio | — | — | → $40 | Downgrade | Outperform → Neutral | Get Alert | |
| 04/21/2023 | OCUL | Buy Now | Ocular Therapeutix | $14.24 | 26.4% | → $18 | Initiates | → Outperform | Get Alert | |
| 02/21/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 327.7% | $90 → $105 | Maintains | Outperform | Get Alert | |
| 11/15/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 11/03/2022 | SURF | Buy Now | Surface Oncology | — | — | $11 → $6 | Maintains | Outperform | Get Alert | |
| 10/19/2022 | AVEO | Buy Now | AVEO Pharmaceuticals | — | — | $17 → $15 | Downgrade | Outperform → Neutral | Get Alert | |
| 09/07/2022 | ISEE | Buy Now | IVERIC bio | — | — | $27 → $34 | Maintains | Outperform | Get Alert | |
| 08/09/2022 | MRSN | Buy Now | Mersana Therapeutics | $27.91 | -28.34% | $18 → $20 | Maintains | Outperform | Get Alert | |
| 08/05/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $6.68 | 109.5% | $17 → $14 | Maintains | Outperform | Get Alert | |
| 08/03/2022 | SURF | Buy Now | Surface Oncology | — | — | $11 → $11 | Maintains | Outperform | Get Alert | |
| 05/09/2022 | SURF | Buy Now | Surface Oncology | — | — | $11 → $11 | Maintains | Outperform | Get Alert | |
| 04/13/2022 | SURF | Buy Now | Surface Oncology | — | — | → $11 | Maintains | Outperform | Get Alert | |
| 04/07/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 1474.07% | $30 → $34 | Maintains | Outperform | Get Alert | |
| 03/03/2022 | ISEE | Buy Now | IVERIC bio | — | — | → $27 | Initiates | → Outperform | Get Alert | |
| 02/25/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 1288.89% | $35 → $30 | Maintains | Outperform | Get Alert | |
| 11/02/2021 | SABS | Buy Now | SAB Biotherapeutics | $3.98 | 477.89% | → $23 | Initiates | → Outperform | Get Alert | |
| 05/06/2020 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 2909.26% | $60 → $65 | Maintains | Outperform | Get Alert | |
| 11/05/2019 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 2677.78% | $56 → $60 | Maintains | Outperform | Get Alert | |
| 02/07/2019 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 1242.59% | → $29 | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved